title: Quantification of an 11C-labelled beta-adrenoceptor ligand, S-(-)CGP 12177, in plasma of humans and rats.
abstract: beta-Adrenoceptors in human lungs and heart can be imaged with the radioligand 4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,3- dihydro-2H-benzimidazol-2-11C-one (CGP 12177, [11C]I). For quantification of receptor density with compartment models by adjustment of rate constants, an 'input function' is required which consists of the integral of the concentration of unmodified ligand in arterial plasma over time. A discrepancy in the literature regarding metabolic stability of [11C]I prompted us to study metabolism in rats by reversed-phase HPLC (RP-HPLC) of trichloroacetic acid extracts of arterial plasma after i.v. injection of [11C]I (> 11.1 TBq/mmol, 11 MBq/kg). Some plasma samples were also directly applied to an internal-surface reversed-phase (ISRP) column. In parallel experiments, tritiated [11C]I was employed and methanol extracts of arterial plasma were analyzed by straight-phase TLC. The three methods were in excellent agreement. Unmodified [11C]I decreased from > 98.5% (3H) or > 99.9% (11C) initially to 57 +/- 7% at 80 min post injection due to formation of two polar metabolites. Using the RP-HPLC method, no metabolism was detectable in humans up to 30 min after injection of [11C]I (1851 MBq). Deproteinization of plasma with acetonitrile resulted in the formation of a radioactive species (artifact) which eluted immediately after the void volume in RP-HPLC and which could be mistakenly interpreted as a metabolite. Plasma protein binding was low (ca. 30%) in both humans and rats.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Positron Emission Tomography (PET) Center, University Hospital, Groningen, Netherlands.
authors.forename: A
authors.initials: A
authors.lastname: van Waarde
authors.forename: R L
authors.initials: RL
authors.lastname: Anthonio
authors.forename: T J
authors.initials: TJ
authors.lastname: Visser
authors.forename: P H
authors.initials: PH
authors.lastname: Elsinga
authors.forename: H
authors.initials: H
authors.lastname: Posthumus
authors.forename: A M
authors.initials: AM
authors.lastname: Weemaes
authors.forename: P K
authors.initials: PK
authors.lastname: Blanksma
authors.forename: G M
authors.initials: GM
authors.lastname: Visser
authors.forename: A M
authors.initials: AM
authors.lastname: Paans
authors.forename: W
authors.initials: W
authors.lastname: Vaalburg
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000378:metabolism*; D000328:Adult; D000818:Animals; D001711:Biotransformation; D001798:Blood Proteins / Q000378:metabolism; D002247:Carbon Isotopes; D002851:Chromatography, High Pressure Liquid; D002855:Chromatography, Thin Layer; D005260:Female; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D008024:Ligands; D008297:Male; D011412:Propanolamines / Q000097:blood* / Q000493:pharmacokinetics; D011485:Protein Binding; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000319:Adrenergic beta-Antagonists; D001798:Blood Proteins; D002247:Carbon Isotopes; D008024:Ligands; D011412:Propanolamines; C033394:CGP 12177